In a report released Monday, analysts at J.P. Morgan predicted that Apple might change its iPhone distribution strategy, launching new devices twice a year starting in 2021.The strategic shift will enable apple to meet seasonal demand and allow it to adjust its products more flexibly over a six-month period and compete better with other device manufacturers that launch new handsets throughout the year.
Since 2011, thanks to holidays and new models,AppleNew releases are usually in September and OctoberIPhone, and set the fourth quarter as the company's largest financial quarter. Analysts at JPMorgan say if Apple releases its new iPhone twice a year, it will be a major strategic shift in Apple's most important product line.
"Based on our survey of the supply chain, we expect a strategic change in the pace of new product launches," said Samik Chatterjee, an analyst at JPMorgan. We expect apple to release two new iPhones in the first half and two in the second half of 2021, which will help seasonal demand. "
Analysts also released their forecast for Apple's 2020 iPhone Series in Monday's report. The report predicts that Apple will launch four new iPhones in September 2020, which is different from the launch strategy of the three iPhone models Apple has adopted since 2017. They also believe that Apple will release low-end products similar to the iPhone 8.
"All four new iPhones in the second half of next year will be equipped with OLED displays, including a 5.4-inch screen, two 6.1-inch screens and one iPhone with a maximum 6.7-inch screen," Chatterjee said. We expect that the two high-end models (6.1 inch and 6.7 inch) will support mmwave, equipped with three shot lens and "world facing" 3D sensor, while the two low-end models (6.1 inch and 5.4 inch) will only support the frequency band below 6GHz, equipped with dual shot lens (without "world facing" 3D sensor). "
Analysts say the increased screen size options and 5g support may encourage current iPhone users to upgrade.
JPMorgan rated Apple overweight and raised its 12-month target price to $296 from $290.